LianBio American Depositary Shares (LIAN)

LIAN was delisted on the 18th of March, 2024.

• Market cap: $34.5M
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: LianBio is a science-driven biopharmaceutical company dedicated to developing and commercializing medicines for patients with unmet medical needs, with an initial focus on in-licensing assets for Greater China and other Asian markets. It is advancing a diversified portfolio of clinically validated product candidates with the potential to drive new standards of care across cardiovascular, oncology, ophthalmology, inflammatory disease, and respiratory indications.

Employees: 163